Published On: April 7th, 2011
Call to Battle: Bacteria containing a gene that confers resistance to many antibiotics have now been found outside the hospital environment in Delhi, India, the WSJ reports. WHO is calling for collective action to develop new antibiotics to combat bacteria incorporating the NDM-1 gene and other so-called “superbugs,” the paper says.
Product Seizure: At the FDA’s behest, U.S. marshals yesterday seized $6 million worth of antiseptic products, wipes and medications sold under the Triad Group and private label brands, MSNBC reports. Products made by Triad and H&P Industries have been linked to infections and death; the FDA said in a statement that the seizure was intended to “stop Triad from continuing to distribute products, which may pose a risk to public health.”
Proxy Fight: Cephalon is fighting for its independence, with Valeant Pharmaceuticals proposing a new slate of board members that would ease the way for a takeover of the company, the WSJ reports. Cephalon has already rejected Valeant’s $73-per-share bid as too low.
From the Gut: A study by Cleveland Clinic researchers suggests that gut bacteria play a role in whether people who eat diets high in animal fats go on to develop heart disease, the Cleveland Plain Dealer reports. The research, published in Nature, finds that mice bred to have no gut bacteria processed animal fat differently and showed no signs of heart disease, the paper says.
Image: iStockphoto

Read the rest here:
A.M. Vitals: WHO Warns on ‘Superbugs’



Did you know:


